Product Pipeline

Pipeline

 
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >

Pipeline

 
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
 
Disc
Pre
P1
P2
P3
Tucatinib (ONT-380) – HER2+ Breast Cancer
 
 
 
 
 
tucatinib + capecitabine (C) + trastuzumab (T) versus
placebo + C + T
 
 
 
 
 
tucatinib + capecitabine + trastuzumab
 
 
 
 
 
tucatinib + T-DM1
 
 
 
 
 
Research Programs
 
 
 
 
 
Cell Cycle Checkpoint
 
 
 
 
 
Immune Checkpoint
 
 
 
 
 
Licensed from Array BioPharma
Licensed from Sentinel Oncology
Research Collaboration with Adimab LLC
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >